Proof of principle for bevacizumab activity in desmoid-type fibromatosis

BACKGROUND: Desmoid-type fibromatosis (DF) is a rare disease, which often occurs in young adults. Medical treatment is an important option in the treatment algorithm of DF. Different chemotherapeutic regimens showed clinical activity in DF, but overall treatment tolerability remains poor for this pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Grünwald, Viktor, Länger, Florian, Raatschen, H. J., Beilken, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819267/
https://www.ncbi.nlm.nih.gov/pubmed/27047656
http://dx.doi.org/10.1186/s13569-016-0045-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819267/
https://www.ncbi.nlm.nih.gov/pubmed/27047656
http://dx.doi.org/10.1186/s13569-016-0045-3

Ejemplares similares